Via Pharmaceuticals
 
  • Home
  • About VIA
    • Management Team
    • Board of Directors
    • Advisors
    • Partnering
  • Product Pipeline
    • Preclinical Drug Candidates
    • VIA-2291
  • Clinical Trials
    • CEA Trial
    • ACS Trial
    • FDG-PET Trial
  • About Inflammation
  • Scientific Publications
  • Investor Relations
    • News
    • Media
  • Newsroom
    • Press Releases
  • Careers
    • Job Opportunities
    • Benefits
  • Contact Us

Company

VIA is a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease. The Company is building a pipeline of small molecule drugs that intervene directly in the chronic inflammation underlying atherosclerosis.

Read more »

Partnering

Our pipeline includes pre-clinical and clinical-stage small-molecule drugs that intervene directly with selected molecular targets in pathways of interest in cardiovascular and metabolic disease.

Read more »

©2008 VIA Pharmaceuticals, Inc.      750 Battery Street, Suite 330 San Francisco CA 94111      office: 415.283.2200      fax: 415.283.2201      info@viapharmaceuticals.com      Legal